Saba Capital Management, L.P. sold HQL
August 26, 2025 · Form 4 insider transaction
Saba Capital Management, L.P. sold 400 shares of Abrdn Life Sciences Investors at $13.83 per share, a transaction worth $5.5K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
400
Price
$13.83
Total value
$5.5K
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 26, 2025
Filing dateAugust 27, 2025
Shares owned after3,006,429
OwnershipIndirect
10b5-1 planNo
AmendedNo